Variant report

Variant	nsv582060
Chromosome Location	chr2:56941668-57137622
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:56994176-56994258	K562	blood:	n/a	n/a
2	ATF1	chr2:57013062-57013304	K562	blood:	n/a	n/a
3	ATF2	chr2:56997583-56998016	GM12878	blood:	n/a	n/a
4	ATF3	chr2:56968638-56969377	A549	lung:	n/a	n/a
5	ATF3	chr2:56968584-56969210	A549	lung:	n/a	n/a
6	BATF	chr2:56997704-56997941	GM12878	blood:	n/a	chr2:56997831-56997842
7	BATF	chr2:56997653-56997934	GM12878	blood:	n/a	chr2:56997831-56997842
8	BATF	chr2:56980310-56980554	GM12878	blood:	n/a	n/a
9	BCL11A	chr2:56997668-56997942	GM12878	blood:	n/a	n/a
10	BCL3	chr2:56968527-56969366	A549	lung:	n/a	n/a
11	BCL3	chr2:56968619-56969314	A549	lung:	n/a	n/a
12	BRCA1	chr2:56958792-56958802	Hela-S3	cervix:	n/a	n/a
13	BRCA1	chr2:56968715-56969165	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr2:57067124-57067469	HCT-116	colon:	n/a	n/a
15	CBX3	chr2:56968576-56969072	HCT-116	colon:	n/a	n/a
16	CCNT2	chr2:57041614-57041799	K562	blood:	n/a	n/a
17	CCNT2	chr2:56997165-56997365	K562	blood:	n/a	n/a
18	CEBPB	chr2:56944997-56945240	HepG2	liver:	n/a	chr2:56945065-56945078 chr2:56945066-56945077
19	CEBPB	chr2:57098783-57099028	A549	lung:	n/a	n/a
20	CEBPB	chr2:56968665-56969269	Hela-S3	cervix:	n/a	chr2:56968916-56968929
21	CEBPB	chr2:57006911-57007265	HepG2	liver:	n/a	chr2:57007078-57007089
22	CEBPB	chr2:57034021-57034373	MCF-7	breast:	n/a	n/a
23	CEBPB	chr2:57006992-57007246	IMR90	lung:	n/a	chr2:57007078-57007089
24	CEBPB	chr2:57072133-57072333	A549	lung:	n/a	n/a
25	CEBPB	chr2:57039646-57040011	MCF-7	breast:	n/a	n/a
26	CEBPB	chr2:57098748-57099073	IMR90	lung:	n/a	n/a
27	CEBPB	chr2:56985119-56985377	HepG2	liver:	n/a	chr2:56985235-56985248 chr2:56985235-56985246 chr2:56985236-56985247
28	CEBPB	chr2:56985109-56985421	A549	lung:	n/a	chr2:56985235-56985248 chr2:56985235-56985246 chr2:56985236-56985247
29	CEBPB	chr2:57037725-57038047	Hela-S3	cervix:	n/a	chr2:57037916-57037927 chr2:57037758-57037775 chr2:57037918-57037929
30	CEBPB	chr2:56968504-56969240	A549	lung:	n/a	chr2:56968916-56968929
31	CEBPB	chr2:57010416-57010803	HepG2	liver:	n/a	chr2:57010540-57010551 chr2:57010503-57010514
32	CEBPB	chr2:57034031-57034462	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr2:57010410-57010654	A549	lung:	n/a	chr2:57010540-57010551 chr2:57010503-57010514
34	CEBPB	chr2:57034077-57034391	A549	lung:	n/a	n/a
35	CEBPB	chr2:57007014-57007204	K562	blood:	n/a	chr2:57007078-57007089
36	CEBPB	chr2:57006977-57007173	A549	lung:	n/a	chr2:57007078-57007089
37	CEBPB	chr2:56968483-56969408	A549	lung:	n/a	chr2:56968916-56968929
38	CEBPB	chr2:57037746-57038047	HepG2	liver:	n/a	chr2:57037916-57037927 chr2:57037758-57037775 chr2:57037918-57037929
39	CEBPB	chr2:57033949-57034555	A549	lung:	n/a	n/a
40	CEBPB	chr2:57098758-57099052	HepG2	liver:	n/a	n/a
41	CEBPB	chr2:56990938-56991146	A549	lung:	n/a	n/a
42	CEBPB	chr2:57092289-57092556	HepG2	liver:	n/a	chr2:57092419-57092430
43	CEBPB	chr2:57020847-57021162	HepG2	liver:	n/a	chr2:57020979-57020990
44	CEBPB	chr2:56945055-56945211	IMR90	lung:	n/a	chr2:56945065-56945078 chr2:56945066-56945077
45	CEBPB	chr2:57088139-57088500	HepG2	liver:	n/a	n/a
46	CEBPB	chr2:56968648-56969351	A549	lung:	n/a	chr2:56968916-56968929
47	CEBPB	chr2:56971118-56971236	HepG2	liver:	n/a	chr2:56971168-56971179
48	CEBPB	chr2:56968732-56969245	IMR90	lung:	n/a	chr2:56968916-56968929
49	CEBPB	chr2:57098783-57099024	H1-hESC	embryonic stem cell:	n/a	n/a
50	CHD2	chr2:56968647-56969159	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:56940349..56941971-chr2:56943071..56945568,2	MCF-7	breast:
2	chr2:56962863..56964748-chr2:56970862..56973633,2	MCF-7	breast:
3	chr2:57078712..57081570-chr2:57085174..57087217,2	MCF-7	breast:
4	chr2:57048488..57050051-chr2:57058805..57060828,2	MCF-7	breast:
5	chr2:57125151..57127960-chr2:57127962..57130049,3	K562	blood:
6	chr2:57078712..57081570-chr2:57085174..57087217,2	MCF-7	breast:
7	chr2:56997703..56999296-chr2:57011926..57014412,2	K562	blood:
8	chr2:56438471..56441225-chr2:57051813..57054565,2	MCF-7	breast:
9	chr2:56919330..56921444-chr2:57050867..57052484,2	MCF-7	breast:
10	chr2:56418873..56419603-chr2:56975911..56976760,2	MCF-7	breast:
11	chr2:57035108..57036803-chr2:57124744..57126282,2	K562	blood:
12	chr2:57037052..57037562-chr2:57367504..57368073,2	MCF-7	breast:
13	chr2:57035108..57036803-chr2:57124744..57126282,2	K562	blood:
14	chr2:56962863..56964748-chr2:56970862..56973633,2	MCF-7	breast:
15	chr2:57069877..57070526-chr8:126036477..126036977,2	MCF-7	breast:
16	chr2:56963796..56964597-chr4:36669358..36670047,2	MCF-7	breast:
17	chr2:57125151..57127960-chr2:57127962..57130049,3	K562	blood:
18	chr2:57011309..57011934-chr2:57604188..57604743,2	MCF-7	breast:
19	chr2:56410661..56411329-chr2:56976031..56976883,5	MCF-7	breast:
20	chr2:56940349..56941971-chr2:56943071..56945568,2	MCF-7	breast:
21	chr2:56997703..56999296-chr2:57011926..57014412,2	K562	blood:
22	chr2:57048488..57050051-chr2:57058805..57060828,2	MCF-7	breast:
23	chr2:56410374..56411316-chr2:56976212..56976966,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CCDC85A-3	chr2:56977435-56977698	NONHSAT070829

Variant related genes	Relation type
ENSG00000231570	TF binding region
ENSG00000055813	chromatin interactions

Extended variants
information (count: 2835 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:2835 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2058993	chr2:56941668-56941669	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs149353893	chr2:56941693-56941694	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs146293757	chr2:56941696-56941697	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs139759639	chr2:56941704-56941705	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs537577107	chr2:56941727-56941728	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs188536380	chr2:56941753-56941754	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs13424603	chr2:56941756-56941757	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs144462995	chr2:56941783-56941784	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs577385994	chr2:56941794-56941795	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs528427225	chr2:56941798-56941799	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs369689503	chr2:56941866-56941867	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs146135210	chr2:56941874-56941875	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs553396088	chr2:56941908-56941909	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs148770046	chr2:56941920-56941921	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs193212651	chr2:56941927-56941928	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs562101515	chr2:56941933-56941934	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs185643745	chr2:56941949-56941950	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs544401776	chr2:56941952-56941953	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs552435474	chr2:56942084-56942085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs71393533	chr2:56942085-56942086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs398060206	chr2:56942096-56942097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs11434165	chr2:56942097-56942098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs189320066	chr2:56942118-56942119	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs180811631	chr2:56942169-56942170	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs546726976	chr2:56942173-56942174	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs142579188	chr2:56942179-56942180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs150953629	chr2:56942187-56942188	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs533072507	chr2:56942224-56942225	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs546614530	chr2:56942254-56942255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs548849678	chr2:56942265-56942266	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs568538853	chr2:56942282-56942283	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs537817214	chr2:56942288-56942289	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs183895992	chr2:56942330-56942331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs188672279	chr2:56942334-56942335	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs374377297	chr2:56942342-56942343	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs79113769	chr2:56942345-56942346	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs553645826	chr2:56942374-56942375	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs573462535	chr2:56942379-56942380	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs181414015	chr2:56942419-56942420	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs62163362	chr2:56942421-56942422	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs140759275	chr2:56942440-56942441	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs544556167	chr2:56942455-56942456	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs144228253	chr2:56942459-56942460	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533513829	chr2:56942463-56942464	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs147759936	chr2:56942467-56942468	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs540360520	chr2:56942489-56942490	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs559949703	chr2:56942521-56942522	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs529032045	chr2:56942530-56942531	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs548884351	chr2:56942554-56942555	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs370123203	chr2:56942570-56942571	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Mental retardation	19951919	CNVD
Myelofibrosis	22110671	CNVD
Microcephaly	20799320	CNVD
camptodactyly	20799320	CNVD
cognitive delay	20799320	CNVD
prenatal and postnatal growth deficiency	20799320	CNVD
ptosis of eyelids	20799320	CNVD
Maculopathy	20981449	CNVD
2p16.1 microdeletion syndrome	22283845	CNVD
Autism	22579565	CNVD
Autism	16963482	CNVD
Autism	21750575	CNVD
idiopathic intellectual disability	16963482	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Multiple myeloma	16616336	CNVD
Follicular lymphoma	17699855	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:56932200-56943000	Weak transcription	Psoas Muscle	Psoas
2	chr2:56940200-56942000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
3	chr2:56940200-56942000	Enhancers	Muscle Satellite Cultured Cells	--
4	chr2:56940200-56943200	Enhancers	Fetal Heart	heart
5	chr2:56940400-56941800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr2:56940400-56942000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr2:56940600-56941800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr2:56941000-56942000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr2:56941200-56941800	Enhancers	NH-A	brain
10	chr2:56941400-56942600	Weak transcription	Skeletal Muscle Female	skeletal muscle
11	chr2:56941400-56945600	Weak transcription	Skeletal Muscle Male	skeletal muscle
12	chr2:56942000-56942400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr2:56942000-56942600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr2:56942400-56942600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr2:56942600-56943000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr2:56942600-56943200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr2:56942600-56943200	Enhancers	Skeletal Muscle Female	skeletal muscle
18	chr2:56943000-56943200	Enhancers	Pancreas	Pancrea
19	chr2:56943000-56943200	Enhancers	Psoas Muscle	Psoas
20	chr2:56943200-56943600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr2:56943200-56945600	Weak transcription	Fetal Heart	heart
22	chr2:56945600-56946000	Enhancers	Fetal Heart	heart
23	chr2:56945600-56946000	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr2:56946800-56947200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr2:56946800-56947200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr2:56947200-56947600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr2:56947200-56947600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr2:56947600-56948200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr2:56947600-56948600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr2:56954000-56955000	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr2:56954600-56955600	ZNF genes & repeats	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr2:56955600-56956200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr2:56956200-56957000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr2:56956200-56957000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr2:56956200-56957000	Enhancers	Muscle Satellite Cultured Cells	--
36	chr2:56957000-56958600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr2:56958800-56959000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr2:56958800-56960800	Enhancers	Fetal Brain Male	brain
39	chr2:56960000-56960400	Enhancers	Brain Germinal Matrix	brain
40	chr2:56965800-56967200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr2:56966200-56967200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr2:56966600-56966800	Enhancers	Muscle Satellite Cultured Cells	--
43	chr2:56966600-56967400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr2:56966800-56968000	Weak transcription	Muscle Satellite Cultured Cells	--
45	chr2:56967400-56967800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr2:56967800-56968400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
47	chr2:56967800-56968600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr2:56968000-56968400	Enhancers	A549	lung
49	chr2:56968000-56968400	Enhancers	HSMMtube	muscle
50	chr2:56968000-56968600	Enhancers	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links